Skip to main content

TERUMO GLOBAL

Select Region

Show — Select Region Hide — Select Region

- Regions/Countries
  - - Japan
    - United States
      - Terumo Interventional Systems
        
        Terumo Cardiovascular
        
        Terumo Neuro
        
        Terumo Blood and Cell Technologies
        
        Terumo Aortic
        
        Terumo Medical Products
        
        Terumo Medical Corp
        
        Terumo Health Outcomes
    - Canada
  - - Europe
    - Latin America
      - Latin America
        
        Mexico
        
        Brazil
        
        Colombia
        
        Chile and Argentina
  - - Asia Pacific
    - Australia
    - Korea
    - Vietnam
    - China
    - India
- Global Business website

About Terumo
About Terumo
Dear Stakeholders
Who We Are
Corporate Governance
Compliance
Regulations and Standards
Procurement Activity
At a Glance
Terumo Group Identity
Leadership Team
History
Terumo’s Purpose
Terumo's Response to COVID-19
Education and Training
Terumo Ventures
Business Overview
Business Overview
TIS Division (Terumo Interventional Systems)
Neurovascular Division (Terumo Neuro)
Cardiovascular Division (Terumo Cardiovascular)/ HeartSheet Division
Vascular Graft Division (Terumo Aortic)
Hospital Care Solutions Division
Life Care Solutions Division
Pharmaceutical Solutions Division
Terumo Blood and Cell Technologies Company (Terumo Blood and Cell Technologies)
Sustainability
Sustainability
Sustainability News
Sustainability at the Terumo Group
Resolving Healthcare Challenges
Creating a Diverse and Inclusive Workplace
Reducing Environmental Footprint
Serving Our Communities
Report Library
GRI Standards Index
Technology
Technology
From Devices to Solutions
Basic Information
Basic Information Top
Research and Development
Production and Supply
Intellectual Property
Terumo Fellows
Stories - Our Technologies
Investors
Investors
Management Policy
Management Policy
Top Management Message
Business Risks
Disclaimer
IR Policy
Financial Highlights
IR Library
IR Library
Financial Statements
Presentations
Consolidated Financial Statements
Terumo Reports
IR Events
Shareholders & Stock
Shareholders Meeting
Stock Information
Shareholder Return
Credit Ratings and Corporate Bond
Analyst Coverage
Articles of Incorporation
Site Quote
IR Inquiries
News
News
January 15, 2025
Corporate
Terumo Launches its Injection Filter Needle, a first step of the INFINO™ -Development Program, to extend the choice for hypodermic and intravitreal injections
December 25, 2024
Financial
Notice Concerning Status and Completion of Acquisition of Own Shares, and Cancellation of Treasury Stock (PDF 90.05 KB)
(Acquisition of the Company's own shares under articles of incorporation pursuant to the paragraph 2 of Article 165 of the Companies Act of Japan, and cancellation of treasury stock pursuant to the Article 178 of the Companies Act of Japan)
December 03, 2024
Financial
Notice Concerning Status of Acquisition of Own Shares (PDF 88.66 KB)
(Acquisition of the Company's own shares under articles of incorporation pursuant to the paragraph 2 of Article 165 of the Companies Act of Japan)
Global Network
Global Network
Japan
North America
South America
Europe, Middle East and Africa
Greater China
Asia and Pacific

Home
News

News

Move to top

Top

Refining Searches

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

Corporate

Financial

December 15, 2016

Corporate

Notice Regarding New Management Team (PDF 69.71 KB)
December 12, 2016

Financial

Terumo Formulates 5-Year Mid- to Long-term Growth Strategy-Aim to Expand in a Ten-Year Perspective as a Global Corporation with Japanese Origins
December 07, 2016

Corporate

Terumo Signs to Acquire Vascular Closure Business and Other Assets of St. Jude Medical and Abbott-Enhancing Company Offerings in the Interventional Access Device Business- (PDF 92.94 KB)
November 10, 2016

Financial

Notice Concerning Adoption of International Financial Reporting Standards (IFRS) (PDF 68.1 KB)
October 18, 2016

Corporate

Terumo to Acquire Portion of Vascular Closure Portfolio and Other Assets of St. Jude Medical and Abbott
August 25, 2016

Financial

Notice Concerning the Determination of Details of Issuance of Stock Options (Share Warrants) (PDF 83.81 KB)
August 04, 2016

Financial

Notice Concerning the Issuance of Stock Options (Share Warrants) (PDF 111.47 KB)
June 24, 2016

Financial

Notice regarding the appointment of Independent Committee Members for the "Policy for Large-scale Acquisitions of Terumo Shares (Takeover Defense Measures" (PDF 104.36 KB)
June 24, 2016

Corporate

Terumo Announces Voting Results for the Election of Directors (PDF 36.14 KB)
June 14, 2016

Corporate

Terumo Acquires Sequent Medical, U.S.-based Developer of New Aneurysm Embolization Device-Accelerating Growth in Neurovascular Treatment-
June 10, 2016

Corporate

FDA Lifts All Remaining Shipping Restrictions at Terumo Cardiovascular Systems' Ann Arbor Facility
June 06, 2016

Corporate

Terumo Launches HeartSheet®: A Global First Cellular and Tissue-based Product Designed for the Treatment of Heart Failure
May 18, 2016

Corporate

Major new study investigating abbreviated DAPT post-stent in high bleeding risk patients announced

Global study involving 4,300 patients from 34 countries announced at EuroPCR
May 10, 2016

Corporate

Terumo Appoints the Candidates for Directors (PDF 35.05 KB)
May 02, 2016

Corporate

Life-Saving Device Brings Eighth Queen's Award

- 1,400 patients' lives saved worldwide thanks to pioneering medical implant -
- Vascutek's device saves hospital providers an estimated £26,000 per operation -
April 18, 2016

Corporate

Terumo Institutes the "Terumo Fellow" Program
March 25, 2016

Financial

Notice Concerning Results and Completion of the Company's Own Shares(Acquisition of the company's own shares pursuant to item 2 of Article 165 of the Corporate Law concerning the provisions of the articles of incorporation) (PDF 14.74 KB)
March 04, 2016

Financial

Notice Concerning the Status of Acquisition of the Company's Own Shares(Acquisition of the company's own shares pursuant to item 2 of Article 165 of the Corporate Law concerning the provisions of the articles of incorporation) (PDF 63.88 KB)
March 04, 2016

Corporate

Terumo's MEDISAFE Fit Smile, a Blood Glucose Meter, Receives an iF Design Award 2016
February 10, 2016

Financial

Notice Concerning Acquisition Results of the Company's Own Shares by ToSTNeT-3 (PDF 17.62 KB)
February 09, 2016

Financial

Notice Concerning Acquisition of the Company's Own Shares through ToSTNeT-3 (PDF 14.04 KB)
February 04, 2016

Financial

Notice Concerning Acquisition of the Company's Own Shares(Acquisition of the company's own shares pursuant to item 2 of Article 165 of the Corporate Law concerning the provisions of the articles of incorporation) (PDF 57.45 KB)
February 04, 2016

Financial

Revision to Full-Year Results Forecast for FY2015 (PDF 49.58 KB)
February 04, 2016

Corporate

Notice Concerning Change of Representative Directors (PDF 97.24 KB)
January 28, 2016

Corporate

Terumo and Quirem Medical Expand Strategic Alliance
November 05, 2015

Financial

Terumo Revises Upward Interim Dividend and Year-End Dividend Forecast for the Fiscal Year Ending March 31, 2016 (PDF 17.28 KB)
September 24, 2015

Financial

Revision to First-Half and Full-Year Results Forecast for FY2015 (PDF 59.8 KB)
September 18, 2015

Corporate

Terumo Receives Approval for the Manufacturer and Sale of its HeartSheet Autologous Skeletal Myoblast Sheets in Japan
September 09, 2015

Corporate

Terumo Invests in Quirem Medical, Focusing on Interventional Oncology Field
September 02, 2015

Corporate

Terumo's Autologous Skeletal Myoblast Sheets Are the First to Be Approved as a Cellular or Tissue-based Products in Japan by a Council of the Ministry of Health, Labour and Welfare
August 12, 2015

Financial

Notice Concerning Acquisition Results of the Company's Own Shares by ToSTNeT-3 (PDF 63.66 KB)
August 11, 2015

Financial

Notice Concerning Acquisition of the Company's Own Shares through ToSTNeT-3 (PDF 21.89 KB)
August 10, 2015

Corporate

Terumo Receives Approval for the Manufacturer and Sale of its Ultimaster Drug-Eluting Coronary Stent in Japan
August 07, 2015

Financial

Notice Concerning the Issuance of Stock Option (Share Warrants) (PDF 84.38 KB)
August 04, 2015

Financial

Notice Concerning Acquisition of the Company's Own Shares(Acquisition of the company's own shares pursuant to item 2 of Article 165 of the Corporate Law concerning the provisions of the articles of incorporation) (PDF 60.58 KB)
June 24, 2015

Financial

Notice regarding the appointment of Independent Committee Members for the "Policy for Large-scale Acquisitions of Terumo Shares (Takeover Defense Measures"
May 28, 2015

Corporate

Terumo to Support Relief Efforts Following Nepal Earthquake
May 19, 2015

Corporate

Terumo Announces CE Mark Clearance for Bioresorbable Scaffold Developed by Arterial Remodeling Technologies (ART)
May 08, 2015

Corporate

Notice Concerning Members of the Board of Directors after the Transition to a Company with an Audit/Supervisory Committee (PDF 56.07 KB)
May 08, 2015

Financial

Notice Regarding Dividend for the Fiscal Year Ended March 31, 2015 (PDF 17.43 KB)
April 23, 2015

Corporate

Notice Concerning Partial Amendment of the Articles of Incorporation (PDF 67.5 KB)
April 23, 2015

Corporate

Notice Concerning Transition to a Company with an Audit/Supervisory Committee (PDF 81.2 KB)
April 17, 2015

Corporate

Regarding the Result of Inspection at Terumo CVS Ann Arbor Plant by U.S. Food & Drug Administration (FDA)
April 10, 2015

Corporate

Daiichi Sankyo and Terumo Announce Application in Japan for Manufacturing and Sales Approval of Intradermal Seasonal Influenza Vaccine
April 06, 2015

Corporate

Terumo and Olympus Expand Interventional System Business Partnership in the U.S. to Cover Urology and Gastroenterology
March 27, 2015

Corporate

FAMHP advises patients to not suspend nor stop any treatments
March 23, 2015

Corporate

Terumo Europe responds to broadcast EenVandaag Injection needles pose no health risks for patients
February 12, 2015

Corporate

Terumo Establishes a New R&D Center for Interventional Business in Southern California, US to Accelerate Worldwide Growth of Interventional Therapeutic Area
February 03, 2015

Financial

Notice Concerning Acquisition of the Company's Own Shares (Acquisition of the company's own shares pursuant to item 2 of Article 165 of the Corporate Law concerning the provisions of the articles of incorporation) (PDF 73.77 KB)

Pagination

Previous page
Page1
…
Page7
Page8
Current page9
Next page

Footer Menu

Show — Footer Menu Hide — Footer Menu

- Investors
- News
  - - News
    - Press Inquiries
- Global Network

About Terumo
Business Overview
Sustainability
Technology
Investors
News
Global Network

Footer

Show — Footer Hide — Footer

Terms and Conditions of Use
Privacy Policy
Cookie Policy
Cookie Settings
Social Media Policy
Site Map

Copyright © 2025 Terumo Corporation, All Rights Reserved.